How the PAM Enzyme is in involved in Energy Production, YouTube Video by Morley Robbins

Here is a comprehensive list of all unique facts presented in the video “What is the PAM Enzyme?” – not commonly known – as explained by Morley Robbins during the discussion:

🧬 UNIQUE FACTS ABOUT THE PAM ENZYME (Peptidylglycine Alpha-Amidating Monooxygenase)

1. PAM activates over 800 signaling peptides in the body.

   • The number of known PAM-activated peptides has grown over time: from 13 → 43 → 70+ → 279 → 827.

   • These peptides include insulin, leptin, ghrelin, TRH, CRH, oxytocin, vasopressin, and many more.

2. PAM enzyme is essential for converting prohormones into active hormones.

   • It modifies peptides by removing the C-terminal glycine and adding an amine group (NH₂), turning them “on”.

3. The PAM enzyme requires four specific conditions to function:

   • Copper

   • Oxygen (monooxygenase action)

   • Ascorbate (not ascorbic acid)

   • Acidic pH (prefers an acidic environment, not alkaline)

4. PAM is not restricted to the hypothalamus.

   • It’s active throughout the entire endocrine system, including the pituitary, adrenals, organs, bones, and tissues.

5. The PAM enzyme is virtually unknown in conventional medicine.

   • It is not taught in medical schools and most doctors have never heard of it.

6. Lab tests only assess the N-terminal of peptides—not the C-terminal where PAM acts.

   • This means medical testing often shows hormone presence without knowing if the hormone is active.

7. The C-terminal is what determines whether a peptide is active.

   • Yet no commercial assays test the C-terminal status of peptides or hormones.

8. PAM activation gives hormones the correct shape to bind to receptors.

   • Without activation, hormones are misshapen, hydrophilic (instead of hydrophobic), and degrade faster (shorter half-life).

⚙️ BIOCHEMICAL & PHYSIOLOGICAL INSIGHTS

9. Insulin resistance may often be due to inactivation, not receptor insensitivity.

   • It’s like a toy without batteries: inactive insulin can’t bind its receptor, hence blood sugar remains high.

10. Chromogranin A (CGA) is a precursor peptide that must be activated before insulin itself can become active.

11. The body’s signaling peptides function like cell phones:

• Without PAM “charging” them, they’re “dead”—no communication between cells.

12. Hyperglycemia causes conformational damage to ceruloplasmin.

• This leads to copper leaking out, which is wrongly interpreted by medicine as “copper toxicity”.

13. Glyphosate, fructose, statins, and antibiotics all deplete or block copper:

• Glyphosate: chelates copper in soil.

• Fructose: blocks the CTR1 copper transporter (shown in Myra Fields’ work).

• Statins: disrupt mitochondria.

• Antibiotics: impair copper status.

14. The PAM enzyme is still functional in venomous animals (snakes, insects, etc.), but not in the humans they bite.

• Venoms target copper enzymes like superoxide dismutase, and PAM in these animals remains operational—humans’ don’t.

15. PAM enzyme dysfunction is recoverable with copper supplementation.

• Confirmed in rodent studies by Richard Mains and Betty Eipper—copper restored PAM activity even with genetic defects.

🔬 COPPER-SPECIFIC INSIGHTS

16. Ceruloplasmin is the master copper protein and antioxidant.

• When hyperglycemia damages it, copper is released—misleadingly interpreted as excess/toxicity.

17. Two copper-transporting enzymes are critical:

• ATP7A (Menkes protein) – Loads copper into most enzymes, including PAM.

• ATP7B (Wilson’s protein) – Loads copper into ceruloplasmin.

18. Retinol (vitamin A) is required for copper-loading enzymes to work.

• Retinol is converted to retinoic acid, a hormone that helps enzymes like ATP7B function.

19. Atox1 is a copper chaperone protein that delivers copper to ATP7A and ATP7B.

20. CTR1 is the “front door” copper transporter into cells, but it’s blocked by fructose.

🩺 METABOLIC & DIAGNOSTIC INSIGHTS

21. Standard lab markers don’t measure peptide activity, only presence.

• All peptide testing is based on N-terminal; C-terminal status is ignored.

22. Uric acid is a waste product of failed ATP production.

• High uric acid = poor mitochondrial function.

• Uric acid acts like black smoke from a broken engine (Robbins analogy).

23. Low uric acid may indicate poor excretion by copper-dependent kidney enzymes.

24. New diagnostic ratio proposed: Ceruloplasmin ÷ Uric Acid

• Ideal for men: 30 ceruloplasmin ÷ 5 uric acid = 6:1

• For women: ~7.5:1 (though Robbins considers simplifying this)

25. Low ratio (<6) suggests copper deficiency and compromised mitochondrial output.

26. Ceruloplasmin can serve as a surrogate marker for Complex IV (cytochrome c oxidase) activity in mitochondria.

📊 DIAGNOSTIC & HISTORICAL RESEARCH

27. Sternlieb and Scheinberg (1960) established the ideal copper:ceruloplasmin ratio as 3.33:1 (100 parts copper to 30 parts ceruloplasmin).

28. Joseph Prohaska found that in copper deficiency:

• SOD (superoxide dismutase) is low

• CCS (its chaperone) is high, as it “searches” for missing copper.

29. Children with Menkes disease (a genetic copper transport disorder) are the most glucose-intolerant humans—demonstrating copper’s essential role in sugar metabolism.

30. Gene-based impairments in copper handling (e.g., ATP7A mutations) are energetically driven and can be improved with correct nutrition and energy restoration.

The reference to the over 800 peptides activated by the PAM enzyme (Peptidylglycine Alpha-Amidating Monooxygenase) is one of the most significant insights in the video. Below is a detailed, precise, and complete expansion about these peptides and the role of PAM in their activation.

🧠 What Are These 800+ Peptides?

They are signaling peptides, also known as neuropeptides, hormones, or peptide messengers. These molecules act like cellular text messages, allowing cells, tissues, and organs to communicate, regulate, and respond to internal and external stimuli.

They are bioactive molecules that:

• Regulate metabolism

• Govern endocrine (hormonal) functions

• Control neurological signals

• Adjust immune, stress, hunger, and reproductive responses

• Maintain homeostasis across multiple systems

🔄 How Does PAM Interact With These Peptides?

The PAM enzyme performs a post-translational modification at the C-terminal glycine residue of these peptides:

1. Removes the carboxyl group (–COOH) at the C-terminal.

2. Replaces it with an amide group (–NH₂), transforming the peptide from an inactive precursor (a “pro-hormone”) into a fully active signaling molecule.

This amidation process is essential for:

• Proper 3D shape of the hormone

• Receptor binding affinity

• Hydrophobicity (so it can pass through membranes or be transported)

• Stability (longer half-life in circulation)

Without this activation:

• The peptides don’t fit into their receptors.

• They degrade faster.

• They cannot deliver their intended message.

📈 How Did the Number Grow to 800+?

Morley Robbins describes the growing awareness in research of PAM’s scope:

This shows that the field of peptide biology and PAM’s role is expanding rapidly, with more peptides being discovered as requiring amidation to function properly.

📱 Analogy: Peptides as Cell Phones

Robbins compares these peptides to cell phones:

• Just as phones need a battery and signal to function,

• Signaling peptides need to be “charged” by PAM to be active.

If they are not amidated, it’s like having a phone that cannot connect, send, or receive messages.

⚙️ Examples of Important PAM-Dependent Peptides

The video mentions specific known peptide hormones activated by PAM:

1. TRH – Thyrotropin-releasing hormone (thyroid regulation)

2. CRH – Corticotropin-releasing hormone (stress regulation via cortisol)

3. Oxytocin – Social bonding, reproduction

4. Vasopressin – Water balance, kidney regulation

5. Insulin – Blood sugar regulation

6. Leptin – Satiety hormone

7. Ghrelin – Hunger hormone

8. Chromogranin A – Precursor for insulin activation

Each of these:

• Begins life as a prohormone or precursor peptide.

• Is inert until PAM modifies it.

• Can only bind and act once amidated.

🔗 Chain of Activation: From Chromogranin A to Insulin

Robbins explains that insulin activation isn’t just about insulin itself—it depends on a cascade:

• Chromogranin A must first be activated.

• That leads to activation of other intermediary peptides.

• Only then can insulin be fully bioactive and functional.

All steps in this signaling cascade rely on PAM enzyme action.

🧬 System-Wide Impact of These Peptides

These peptides operate in:

• Neuroendocrine system (brain-hormone interface)

• Enteroendocrine system (gut hormones)

• Exocrine system (digestive, glandular)

• Paracrine/autocrine signaling (local cell-to-cell messaging)

Their activation is central to regulating the body:

• Blood sugar

• Hunger/satiety

• Reproduction

• Stress response

• Mood and emotion

• Immune regulation

• Inflammation

• Growth and repair

If even a fraction of these 827 peptides are inactive, the entire communication network of the body collapses into dysfunction.

❗ Consequences of Inactivation

When PAM fails to activate these peptides:

• Hormones may be present in labs but non-functional.

• Signals don’t reach their targets → metabolic chaos.

• Sugar builds up → hyperglycemia, insulin resistance.

• Peptide hormones degrade prematurely.

• Body loses ability to adapt to stress, food, light, toxins.

Robbins describes this as like having:

“Parked cars on a highway that can’t be driven.”

💡 Summary

• The PAM enzyme activates 827+ known peptides critical to human health.

• Without PAM, these peptides are chemically inactive and useless.

• PAM requires copper, oxygen, ascorbate, and acidic pH.

• Its failure contributes to widespread hormonal, metabolic, and neurological dysfunction.

• This is a hidden yet central mechanism—unknown to most practitioners, not taught in schools, and not measured in clinical labs.

a complete list of all ~800 peptides that are substrates of the PAM enzyme because there isn’t a single publicly available, definitive “list of 827 peptides” in the scientific literature that’s easy to extract — most published research describes classes of peptides or examples, not an indexed catalog of every known substrate. What is clear from research on peptidylglycine α‑amidating monooxygenase (PAM) is:

❗ What We Do Know From Research

1. PAM amidates many signaling and peptide hormones
PAM is the sole enzyme in humans (and animals) that catalyzes C‑terminal α‑amidation, a post‑translational modification required for full activation of many bioactive peptides.

2. “More than half” of peptide hormones are amidated
Scientific reviews indicate that more than half of all mammalian peptide hormones and a large proportion of invertebrate hormones contain a C‑terminal amide — meaning they depend on PAM or its reaction products for activity.

3. Research articles discuss many examples, not a master list
Published studies frequently cite specific amidated peptides in particular contexts:
• Adrenomedullin (ADM) — amidation required for full activity (e.g., adrenomedullin‑Gly substrates)
• Calcitonin gene‑related peptide (CGRP) — requires amidation for activity
• Neuropeptide Y (NPY) — amidated form is functional
• Amylin and related peptides — amidated peptide hormones
• Islet amyloid polypeptide (IAPP) — PAM substrate, relevant to diabetes research

These examples show types of peptides that depend on PAM but do not constitute a complete list.

📌 Why There’s No Single Public “927/800 Peptide” List

Actual research articles and protein databases do not publish a ready‑made spreadsheet of every PAM substrate. Instead:

• PAM is defined functionally: it modifies any peptide with a C‑terminal glycine that becomes amidated in vivo.

• The practical “universe” of PAM substrates is high because amidation is such a common modification in neuroendocrine and endocrine peptide signaling.

• Many peptides are studied only in niche contexts (e.g., insect hormones, ubiquitin‑related peptides) and aren’t aggregated into one list.

🧠 Example Substrate Categories (with typical examples)

While not exhaustive, the research literature consistently identifies these classes of PAM‑dependent peptides:

🎯 Endocrine Peptides

• Insulin‑like peptides

• Glucagon‑like peptides (e.g., GLP‑1)

• Islet amyloid polypeptide (IAPP)

• Calcitonin family peptides (e.g., CGRP)

🧠 Neuropeptides

• Neuropeptide Y (NPY)

• Substance P (mentioned in PAM research)

• Thyrotropin‑releasing hormone (TRH)

• Oxytocin, Vasopressin (classic amidated neuropeptides)

🧬 Ubiquitin‑Related Peptides

• Ubiquitin (Ub) and Ub‑derived peptides have been shown experimentally to act as PAM substrates under some conditions.

🦠 Other Signaling Molecules

Many peptides involved in growth, pain modulation, appetite, blood pressure regulation, stress, and energy balance are amidated.

📈 Summary (What This Means)

✅ PAM is a universal amidation enzyme:
It catalyzes the last step in the biosynthesis of hundreds of biologically active peptides — especially neuropeptides and hormones.

✅ “800+ peptides” refers to the estimated number of known or potential PAM substrates in modern protein/peptide databases, reflecting how widespread C‑terminal amidation is.

❌ There is no ready‑to‑copy authoritative list of every PAM substrate published as a single list in the public literature.

📌 Options for Accessing Substrate Data

If you want an actual database‑style list of PAM substrates (peptide sequences):

1. Bioinformatics databases (like UniProt, PeptideAtlas, or NeuroPep) list peptides with C‑terminal amidation annotations — which implies PAM dependence.

2. Protein/peptide reference libraries categorize known hormones and neuropeptides, many of which are amidated.

3. Custom literature meta‑analysis that extracts sequences from PAM studies.